688443 fundamentals
An in-depth look to CHONGQING GENRIX BIOPHARMACEUTICAL operating, investing, and financing activities
688443 free cash flow for Q3 24 is -176.63 M CNY. For 2023, 688443 free cash flow was -468.56 M CNY and operating cash flow was -377.58 M CNY.
Q1 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q1 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM